Erin M Bertino Selected Research

Erin M Bertino Research Topics

Disease

18	Neoplasms (Cancer) 02/2023 - 08/2011
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2010
2	Thrombocytopenia (Thrombopenia) 05/2022 - 01/2021
2	Disease Progression 03/2022 - 10/2019
2	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 08/2011
2	Pneumonia (Pneumonitis) 11/2020 - 11/2018
1	Hepatitis 05/2023
1	Lymphoma (Lymphomas) 03/2022
1	Cachexia 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Pain (Aches) 06/2021
1	Substance-Related Disorders (Drug Abuse) 06/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Hypertension (High Blood Pressure) 10/2019
1	Proteinuria 10/2019
1	Diarrhea 10/2019
1	Fanconi Anemia (Fanconi's Anemia) 01/2019
1	Adenocarcinoma of Lung 08/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Hemoptysis 11/2015
1	Malignant Pleural Effusion 01/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2011
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 08/2011
1	Drug-Related Side Effects and Adverse Reactions 08/2011
1	Breast Neoplasms (Breast Cancer) 05/2010
1	Carcinoid Tumor (Carcinoid) 10/2009

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 05/2023 - 10/2019
3	Bevacizumab (Avastin)FDA Link 10/2019 - 12/2010
2	Tyrosine Kinase InhibitorsIBA 03/2022 - 12/2010
2	AlbuminsIBA 01/2022 - 11/2015
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 11/2015
2	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 11/2015
1	Circulating Tumor DNAIBA 03/2022
1	brigatinibIBA 03/2022
1	alectinibIBA 03/2022
1	ceritinibIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 06/2021
1	osimertinibIBA 01/2021
1	navitoclaxIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	acalabrutinibIBA 12/2020
1	ibrutinibIBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	ErbB Receptors (EGF Receptor)IBA 10/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018
1	pazopanib FDA Link 11/2018
1	dabrafenibIBA 11/2018
1	xylometazoline (stas)IBA 08/2017
1	AntibodiesIBA 11/2016
1	B7-H1 AntigenIBA 11/2016
1	Proteins (Proteins, Gene)FDA Link 11/2016
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	Caveolin 1IBA 11/2015
1	PlatinumIBA 11/2015
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	Docetaxel (Taxotere)FDA Link 01/2013
1	Capecitabine (Xeloda)FDA Link 01/2013
1	Histone Deacetylase InhibitorsIBA 08/2011
1	romidepsin (FK228)FDA Link 08/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2011
1	Angiogenesis InhibitorsIBA 12/2010
1	ixabepilone (BMS 247550)FDA Link 05/2010
1	TOR Serine-Threonine KinasesIBA 10/2009

Therapy/Procedure

10	Therapeutics 05/2022 - 10/2009
5	Palliative Care (Palliative Therapy) 02/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
3	Radiotherapy 01/2022 - 01/2018
2	Immunotherapy 10/2019 - 11/2018